Topic

California

A collection of 516 issues

How to Renew Bavencio (Avelumab) Coverage with Aetna CVS Health in California: 2025 Requirements & Timeline

Quick Answer: Renewing Your Bavencio Coverage To renew Bavencio (avelumab) with Aetna CVS Health in California, submit your continuation request at least 14 days before your next infusion using form GR-69328. You'll need recent imaging showing no disease progression, oncology notes confirming tolerability, and documentation of continuous months

How to Get Tagrisso (osimertinib) Covered by Blue Cross Blue Shield in California: Prior Authorization Forms, Appeal Process & Success Strategies

Answer Box: Getting Tagrisso Covered in California Blue Cross Blue Shield plans in California require prior authorization for Tagrisso (osimertinib) with documented EGFR mutations in NSCLC. Submit electronically via CoverMyMeds or the plan's provider portal with pathology reports showing EGFR testing results. If denied, file an internal appeal

Myths vs. Facts: Getting Onpattro (patisiran) Covered by Blue Cross Blue Shield in California

Answer Box: Onpattro Coverage with Blue Shield California Getting Onpattro (patisiran) covered by Blue Shield of California requires prior authorization with genetic TTR mutation proof, neurologist evaluation, and ICD-10 code E85.1 documentation. Submit via AuthAccel portal with clinical records showing hATTR polyneuropathy and functional status. If denied, file internal

How to Get Lamzede (Velmanase Alfa-Tycv) Approved by Cigna in California: Complete Prior Authorization Guide

Answer Box: Getting Lamzede Covered by Cigna in California Cigna requires prior authorization for Lamzede (velmanase alfa-tycv) in California. Submit via eviCore, CoverMyMeds, or Accredo's iAssist with confirmed alpha-mannosidosis diagnosis (enzyme/genetic testing), specialist letter, and clinical documentation. Standard review: 5 business days; expedited: 24 hours for urgent

How to Get Takhzyro (lanadelumab-flyo) Covered by Blue Cross Blue Shield California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Takhzyro Covered by Blue Cross Blue Shield California Blue Cross Blue Shield California requires prior authorization for Takhzyro (lanadelumab-flyo) for hereditary angioedema (HAE). To get approved: (1) Your doctor submits a PA request with HAE diagnosis confirmation (low C4/C1-INH labs), attack frequency logs, and failed step

How to Get Gattex (Teduglutide) Covered by UnitedHealthcare in California: Appeals, Forms & Timelines

Answer Box: Getting Gattex Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Gattex (teduglutide) with strict medical necessity criteria: documented short bowel syndrome, ≥12 months of parenteral nutrition dependence (≥3 days/week), recent colonoscopy, and specialist involvement. If denied, California residents can appeal internally, then request an Independent

How to Get Opsumit (macitentan) Covered by Cigna in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Opsumit Covered by Cigna in California Cigna requires prior authorization for Opsumit (macitentan) with specific PAH criteria. Your fastest path: 1) Confirm WHO Group I PAH diagnosis with right heart catheterization data, 2) Document failed trials of preferred ERAs (ambrisentan/bosentan), 3) Submit PA via CoverMyMeds or

How to Get Lutathera Covered by Humana in California: Prior Authorization Forms, Appeal Process & Success Strategies

Answer Box: Getting Lutathera Covered by Humana in California Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Humana and is covered under Medicare Part B as a medical benefit. Key requirements include SSTR-positive PET imaging and documented failure/progression on somatostatin analogs like octreotide or lanreotide. If denied, California residents

How to Get HyperHEP Covered by Humana in California: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting HyperHEP Covered by Humana in California Humana requires prior authorization for HyperHEP (hepatitis B immune globulin) in California. Submit documentation of exposure details, patient immunity status, and timing within 24 hours (up to 7 days) via Humana's provider portal. For denials, file an internal appeal

How to Get Daybue (trofinetide) Covered by Blue Cross Blue Shield California: Forms, Appeals, and State Protections

Answer Box: Getting Daybue Covered in California Blue Shield of California requires prior authorization for Daybue (trofinetide) with specific clinical criteria: confirmed Rett syndrome with MECP2 mutation, age ≥2 years, and neurologist prescriber. Initial approval covers 3 months, renewals require evidence of clinical benefit. If denied, California's Independent